Company page
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. is a public company traded under the ticker MAZE in the American market. The company has a market capitalization of approximately $1.42 billion. Maze Therapeutics focuses on developing innovative therapies to address genetic diseases.
- Ticker
- MAZE:NASDAQ
- Asset type
- Stock
- Market cap
- $1.42B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD